News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kissei Pharmaceutical Co., Ltd. Announces New Drug Application for Silodosin has been Filed with FDA


2/13/2008 12:27:33 PM

Tokyo, Japan, Feb 13, 2008 - (JCN Newswire) - Kissei Pharmaceutical Co., Ltd (TSE: 4547) announced today that a new drug application for Silodosin (Brand name in Japan: Urief(R)), a novel drug for dysuria associated with Benign Prostatic Hyperplasia (BPH), originally developed by Kissei Pharmaceutical Co., Ltd, and previously licensed-out to Watson Pharmaceuticals, Inc. (US), has been filed with U.S. Food and Drug Administration (FDA).

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES